Skip to content

Study · Randomized controlled trial · n = 60 · 2022

6 results

The safety and efficacy of add-on use of oxytocin in uterine leiomyoma patients undergoing high-intensity focused ultrasound and ultrasound-guided intratumoral ethanol injection: a randomized controlled trial.

Zhang R, Zhang Y, Yang Z, Chen J, Wang Q, Ma J, Zhang B, Zhang H

Annals of palliative medicine1 Jun 2022Cited by 4 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study6

6 results from studies that gave the peptide. 6 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In women with uterine leiomyoma treated with HIFU and ethanol injection, add-on oxytocin did not change the volume ablation rate compared with treatment without oxytocin.

    In plain wordsIn women with uterine fibroids, adding oxytocin to the treatment did not change how much of the fibroid was destroyed.

    Peptide
    Oxytocin
    Outcome
    No significant changeLeiomyoma volume ablation rate
    Study

    n = 60

    Comparator
    HIFU plus ethanol injection without oxytocin
    Outcome group
    Uterine fibroid outcomes · Reproductive and sexual health
    Studied dose
    Dose not stated · injectionAs given in this study (human).

    Source sentences

    Summary
    There were no statistically significant differences between the 2 groups in terms of leiomyoma volume ablation rate (94.48%±2.07% vs. 94.91%±2.53%, P=0.36), crumb gray time (150.70±57.51 vs. 165.77±77.13 s, P=0.37), total treatment energy (556,835.0±202,583 vs. 512,610.0±158,004 J, P=0.19), and tota…
    1 context sentence
    Summary · context
    A total of 60 patients with uterine leiomyomas were included and randomly divided into study group and control group. The patients in the control group were treated with HIFU and ultrasound-guided percutaneous anhydrous ethanol injection, while the study group received oxytocin injection in addition…
  2. 02HumanRandomized controlled trialEfficacy outcome

    In women with uterine leiomyoma treated with HIFU and ethanol injection, add-on oxytocin did not change crumb gray time compared with treatment without oxytocin.

    In plain wordsIn women with uterine fibroids, adding oxytocin did not change the crumb gray time of the procedure compared with treatment without it.

    Peptide
    Oxytocin
    Outcome
    No significant changeCrumb gray time
    Study

    n = 60

    Comparator
    HIFU plus ethanol injection without oxytocin
    Outcome group
    Uterine fibroid outcomes · Reproductive and sexual health
    Studied dose
    Dose not stated · injectionAs given in this study (human).

    Source sentences

    Summary
    There were no statistically significant differences between the 2 groups in terms of leiomyoma volume ablation rate (94.48%±2.07% vs. 94.91%±2.53%, P=0.36), crumb gray time (150.70±57.51 vs. 165.77±77.13 s, P=0.37), total treatment energy (556,835.0±202,583 vs. 512,610.0±158,004 J, P=0.19), and tota…
    1 context sentence
    Summary · context
    A total of 60 patients with uterine leiomyomas were included and randomly divided into study group and control group. The patients in the control group were treated with HIFU and ultrasound-guided percutaneous anhydrous ethanol injection, while the study group received oxytocin injection in addition…
  3. 03HumanRandomized controlled trialEfficacy outcome

    In women with uterine leiomyoma treated with HIFU and ethanol injection, add-on oxytocin did not change total treatment energy compared with treatment without oxytocin.

    In plain wordsIn women with uterine fibroids, adding oxytocin did not change the total energy used in treatment compared with treatment without it.

    Peptide
    Oxytocin
    Outcome
    No significant changeTotal treatment energy
    Study

    n = 60

    Comparator
    HIFU plus ethanol injection without oxytocin
    Outcome group
    Uterine fibroid outcomes · Reproductive and sexual health
    Studied dose
    Dose not stated · injectionAs given in this study (human).

    Source sentences

    Summary
    There were no statistically significant differences between the 2 groups in terms of leiomyoma volume ablation rate (94.48%±2.07% vs. 94.91%±2.53%, P=0.36), crumb gray time (150.70±57.51 vs. 165.77±77.13 s, P=0.37), total treatment energy (556,835.0±202,583 vs. 512,610.0±158,004 J, P=0.19), and tota…
    1 context sentence
    Summary · context
    A total of 60 patients with uterine leiomyomas were included and randomly divided into study group and control group. The patients in the control group were treated with HIFU and ultrasound-guided percutaneous anhydrous ethanol injection, while the study group received oxytocin injection in addition…
  4. 04HumanRandomized controlled trialEfficacy outcome

    In women with uterine leiomyoma treated with HIFU and ethanol injection, add-on oxytocin did not change total treatment time compared with treatment without oxytocin.

    In plain wordsIn women with uterine fibroids, adding oxytocin did not change how long the treatment took compared with treatment without it.

    Peptide
    Oxytocin
    Outcome
    No significant changeTotal treatment time
    Study

    n = 60

    Comparator
    HIFU plus ethanol injection without oxytocin
    Outcome group
    Uterine fibroid outcomes · Reproductive and sexual health
    Studied dose
    Dose not stated · injectionAs given in this study (human).

    Source sentences

    Summary
    There were no statistically significant differences between the 2 groups in terms of leiomyoma volume ablation rate (94.48%±2.07% vs. 94.91%±2.53%, P=0.36), crumb gray time (150.70±57.51 vs. 165.77±77.13 s, P=0.37), total treatment energy (556,835.0±202,583 vs. 512,610.0±158,004 J, P=0.19), and tota…
    1 context sentence
    Summary · context
    A total of 60 patients with uterine leiomyomas were included and randomly divided into study group and control group. The patients in the control group were treated with HIFU and ultrasound-guided percutaneous anhydrous ethanol injection, while the study group received oxytocin injection in addition…
  5. 05HumanRandomized controlled trialSafety outcome

    In women with uterine leiomyoma treated with HIFU and ethanol injection, the pain score was higher with add-on oxytocin than with treatment without oxytocin.

    In plain wordsIn women with uterine fibroids, pain scores were higher when oxytocin was added than with the same treatment without oxytocin.

    Peptide
    Oxytocin
    Outcome
    IncreasePain score
    Study

    n = 60

    Comparator
    HIFU plus ethanol injection without oxytocin
    Outcome group
    Pain · Reproductive and sexual health
    Studied dose
    Dose not stated · injectionAs given in this study (human).

    Source sentences

    Summary
    The pain score of the oxytocin group was significantly greater than that in the control group (4.53±1.55 vs. 3.60±1.19, P=0.008).
    1 context sentence
    Summary · context
    A total of 60 patients with uterine leiomyomas were included and randomly divided into study group and control group. The patients in the control group were treated with HIFU and ultrasound-guided percutaneous anhydrous ethanol injection, while the study group received oxytocin injection in addition…
  6. 06HumanRandomized controlled trialEfficacy outcome

    In women with uterine leiomyoma treated with HIFU and ethanol injection, residual necrotic leiomyoma volume at 3 months and 1 year did not differ between add-on oxytocin and treatment without oxytocin.

    In plain wordsIn women with uterine fibroids, the leftover fibroid volume at 3 months and 1 year was no different with added oxytocin.

    Peptide
    Oxytocin
    Outcome
    No significant changeResidual necrotic leiomyoma volume at 3 months and 1 year
    Study

    n = 60

    Comparator
    HIFU plus ethanol injection without oxytocin
    Outcome group
    Uterine fibroid outcomes · Reproductive and sexual health
    Studied dose
    Dose not stated · injectionAs given in this study (human).

    Source sentences

    Summary
    At 3 months and 1-year post-therapy, no statistically significant differences were observed in the residual necrotic leiomyoma volume between the 2 groups.
    1 context sentence
    Summary · context
    A total of 60 patients with uterine leiomyomas were included and randomly divided into study group and control group. The patients in the control group were treated with HIFU and ultrasound-guided percutaneous anhydrous ethanol injection, while the study group received oxytocin injection in addition…

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:48 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.